论文部分内容阅读
目的探讨低分子肝素钙抗凝配合综合治疗在PNS应用。方法将172例PNS分为治疗组和对照组进行临床观察指标和疗效判定。结果两组在临床观察指标和临床疗效判定上有显著差异性(P<0.01)。结论应用抗凝低分子肝素可降低高凝状态,减少尿蛋白,在PNS应及早应用,持续应用,可作为PNS临床一线用药。
Objective To investigate the application of low molecular weight heparin anticoagulant combined therapy in PNS. Methods 172 cases of PNS were divided into treatment group and control group for clinical observation and efficacy evaluation. Results There were significant differences between clinical observation and clinical judgment (P <0.01). Conclusion The application of anticoagulant low molecular weight heparin can reduce hypercoagulable state and reduce urinary protein, and should be applied as early as possible in PNS and be used continuously as first-line PNS clinical medicine.